-
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints
pharmaceutical-business-review
January 14, 2020
VBI Vaccines has reported top-line data from CONSTANT, the second pivotal Phase 3 study, assessing lot-to-lot manufacturing consistency of Sci-B-Vac, the company’s trivalent hepatitis B (HBV) vaccine ...
-
Internally-developed vaccines reportedly approved in China
europeanpharmaceuticalreview
January 09, 2020
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers’ products.
-
Report indicates seasonal influenza vaccine market in Asia will reach $1bn by 2028
europeanpharmaceuticalreview
January 06, 2020
A new report indicates that drug launches and new formulations will drive the growth of the seasonal influenza vaccine market in China, India and Japan from $914m in 2018 to $1.05bn in 2028.
-
Intravenous delivery of TB vaccine found to dramatically improve potency in models
europeanpharmaceuticalreview
January 03, 2020
New research has shown that intravenous injection of the BCG vaccine dramatically reduces monkey susceptibility to TB bacteria and lung inflammation.
-
Protection Similar With Single, Multiple HPV Vaccine Doses
drugs
December 30, 2019
U.S. women who have received one dose of human papillomavirus (HPV) vaccine have similar protection as women who have received two or three doses ...
-
CRUK partners with Vaccitech on NSCLC immunotherapeutic vaccine
pharmaceutical-technology
December 19, 2019
Vaccitech has signed a partnership with Cancer Research UK (CRUK) to clinically advance VTP-600, the former’s immunotherapy vaccine candidate, for patients with non-small cell lung cancer (NSCLC).
-
Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
americanpharmaceuticalreview
December 17, 2019
Soligenix has opened the study titled "A Phase 1C, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety of RiVax® ...
-
A vaccine against chronic inflammatory diseases
worldpharmanews
December 17, 2019
Chronic inflammatory bowel diseases, such as Crohn's Disease and ulcerative colitis, are linked to abnormalities of the gut microbiota in humans and in animals.
-
Pfizer to debut podcast series around vaccines
fiercepharma
December 12, 2019
Pfizer’s latest podcast is a documentary-style dive into vaccines. The eight-part series, called “The Antigen,” launches in mid-December and tackles the scientific ...
-
Technique to manufacture virus-like particle polio vaccines developed
europeanpharmaceuticalreview
December 10, 2019
University of Leeds researchers have discovered a method to produce polio vaccines made from virus-like particles, which is being trialled on a manufacturing platform.